Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines

Details for Australian Patent Application No. 2004237951 (hide)

Owner Pfizer Products Inc.

Inventors Romano, Steven Joseph

Agent Allens Arthur Robinson

Pub. Number AU-A-2004237951

PCT Pub. Number WO2004/100992

Priority 60/471,188 16.05.03 US

Filing date 3 May 2004

Wipo publication date 25 November 2004

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 025/22 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

A61P 025/18 Drugs for disorders of the nervous system

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/100992 Priority application(s): WO2004/100992

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237952-'(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists

2004237949-Apparatus and method of separating plastic films from garbage for collection